Cargando…
HNRNPA2B1 is a potential biomarker of breast cancer related to prognosis and immune infiltration
Objective: HNRNPA2B1, one of the regulator of m6A methylation, is involved in a wide range of physiological processes. However, the aberrant expression of HNRNPA2B1 in Breast Cancer (BC) and its clinical significance still need to be further studied. Methods: We used related databases to analyze the...
Autores principales: | Ayoufu, Aisikeer, Yi, Lina, Tuersuntuoheti, Muhairemu, Li, Yongtao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10522385/ https://www.ncbi.nlm.nih.gov/pubmed/37671941 http://dx.doi.org/10.18632/aging.204992 |
Ejemplares similares
-
RUSC1‐AS1 promotes the malignant progression of breast cancer depending on the regulation of the miR‐326/XRCC5 pathway
por: Ayoufu, Aisikeer, et al.
Publicado: (2023) -
HSPA8 Is a New Biomarker of Triple Negative Breast Cancer Related to Prognosis and Immune Infiltration
por: Ying, Bicheng, et al.
Publicado: (2022) -
Identification of STAT5B as a biomarker associated with prognosis and immune infiltration in breast cancer
por: Li, Jiaying, et al.
Publicado: (2023) -
Heparanase is a novel biomarker for immune infiltration and prognosis in breast cancer
por: Yang, Wen-Jing, et al.
Publicado: (2021) -
Compensatory expression regulation of highly homologous proteins HNRNPA1 and HNRNPA2
por: CHANG, Yan, et al.
Publicado: (2021)